Schwarz Agatha, Maeda Akira, Schwarz Thomas
Department of Dermatology, University Kiel, Schittenhelmstrasse 7, 24105 Kiel, Germany.
J Immunol. 2007 Jan 15;178(2):877-86. doi: 10.4049/jimmunol.178.2.877.
UV radiation-induced regulatory T cells (UV-Treg) inhibit the sensitization but not the elicitation of contact hypersensitivity when injected i.v. Because UV-Treg express the lymph node homing receptor CD62 ligand, upon i.v. injection they migrate into the lymph nodes but not into the periphery and therefore inhibit sensitization but not elicitation. We tried to modify the migratory behavior of UV-Treg with the aim to get them into the periphery and thereby to suppress the effector phase of immune reactions. Because the tissue selective homing of T effector cells is determined by tissue-specific dendritic cells (DC), we attempted to reprogram the migratory behavior of UV-Treg by DC. 2,4-Dinitrofluorobencene (DNFB)-specific UV-Treg coincubated with epidermal Langerhans cells (LC) blocked the elicitation upon i.v. injection into DNFB-sensitized mice. In contrast, i.v. injection of UV-Treg not incubated with LC did not inhibit the ear challenge. The same negative effect was observed for UV-Treg coincubated with DC from bone marrow, spleen, or lymph nodes. This effect was not due to different maturation stages as checked by MHC class II expression of the different DC types. Incubation with LC but not with bone marrow-derived DC down-regulated the expression of CD62 ligand on UV-Treg. Accordingly, CFDA-SE labeled UV-Treg coincubated with LC were found in the ears but not in the lymph nodes upon i.v. injection. This finding shows that the migratory behavior can be reprogrammed by tissue-specific DC and may have input on strategies trying to use Treg not only for the prevention but also for the treatment of immune-mediated diseases.
紫外线辐射诱导的调节性T细胞(UV-Treg)经静脉注射后可抑制接触性超敏反应的致敏阶段,但不抑制激发阶段。由于UV-Treg表达淋巴结归巢受体CD62配体,静脉注射后它们会迁移至淋巴结而非外周,因此抑制致敏而非激发。我们试图改变UV-Treg的迁移行为,以使它们进入外周,从而抑制免疫反应的效应阶段。由于效应性T细胞的组织选择性归巢由组织特异性树突状细胞(DC)决定,我们尝试通过DC对UV-Treg的迁移行为进行重新编程。与表皮朗格汉斯细胞(LC)共孵育的2,4-二硝基氟苯(DNFB)特异性UV-Treg经静脉注射到DNFB致敏小鼠体内后可阻断激发反应。相比之下,未与LC共孵育的UV-Treg经静脉注射则不抑制耳部激发反应。对于与来自骨髓、脾脏或淋巴结的DC共孵育的UV-Treg也观察到同样的阴性效应。通过不同DC类型的MHC II类表达检查发现,这种效应并非由于不同的成熟阶段。与LC共孵育而非与骨髓来源的DC共孵育可下调UV-Treg上CD62配体的表达。因此,静脉注射后,在耳部而非淋巴结中发现了与LC共孵育的CFDA-SE标记UV-Treg。这一发现表明,迁移行为可由组织特异性DC重新编程,这可能为不仅试图利用Treg预防而且治疗免疫介导疾病的策略提供依据。